Associated Papers
Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors.
Nteliopoulos G et al.
Haematologica, 2019
Select a paper to view details
Nteliopoulos G et al.
Haematologica, 2019